Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Hopes fade for AstraZeneca and Rigel's arthritis pill
Reuters
Thursday, December 13, 2012 - 11:05am
tags:
Rigel, AstraZeneca, fostamatinib, Humira, Abbott Labs, rheumatoid arthritis
1 Small Pharma Proving That Partnerships Pay
Motley Fool
Thursday, December 13, 2012 - 11:04am
tags:
Isis Pharmaceuticals, Biogen Idec
Pfizer to Pay $55 Million in Drug Misbranding Case
Motley Fool
Thursday, December 13, 2012 - 11:02am
tags:
Pfizer, misbranding, GERD, Wyeth, Protonix
Biotech Corner: Monoclonal Antibody Companies
Seeking Alpha
Wednesday, December 12, 2012 - 10:19am
tags:
monoclonal antibodies, Adcetris, Seattle Genetics, Progenics
Assessing Arena's Belviq As A Diabesity Drug
Seeking Alpha
Wednesday, December 12, 2012 - 10:17am
tags:
Belviq, Arena Pharmaceuticals, obesity, diabetes
Sucampo Pharma jumps in premarket after FDA OK of sNDA for Rescula
Reuters
Wednesday, December 12, 2012 - 10:16am
tags:
Sucampo, FDA, Rescula, open angle glaucoma, ocular hypertension
The US Department of Justice's targeting of medical speech and its public health impacts
American Enterprise Institute
Wednesday, December 12, 2012 - 10:06am
tags:
DOJ, off-label
Gilead to buy YM BioSciences for about $465 million
Reuters
Wednesday, December 12, 2012 - 10:02am
tags:
YM BioSciences, M&A, Gilead Sciences
Janssen submits NDA to FDA for canagliflozin/metformin
Yahoo/Fly on the Wall
Wednesday, December 12, 2012 - 10:01am
tags:
Janssen, FDA, canagliflozin, diabetes, metformin
Lilly Alzheimer’s Drug Delayed on Need for Added Study
Bloomberg
Wednesday, December 12, 2012 - 9:58am
tags:
Eli Lilly, Alzheimer's disease, solanezumab
Another door closes on Abbott
CP Wire
Wednesday, December 12, 2012 - 8:27am
tags:
China, Bioporto, Abbott Labs
Medtronic fines make up nearly half of Minn. Attorney's 2012 collections
Mass Device
Wednesday, December 12, 2012 - 8:18am
tags:
Minnesota, Medtronic
Medical device tax is here to stay, says AdvaMed chairman James Mazzo
Mass Device
Wednesday, December 12, 2012 - 8:14am
tags:
devices, device tax, AdvaMed
The Medicines Co., Bristol-Myers sign global alliance pact for Recothrom
Yahoo/Fly on the Wall
Wednesday, December 12, 2012 - 8:13am
tags:
Bristol-Myers Squibb, Recothrom, Medicines Company, recombinant thrombin
The Next Wave of Diabetes Dominance
Motley Fool
Wednesday, December 12, 2012 - 8:11am
tags:
diabetes, Bayer, Sanofi, Novo Nordisk, Abbott Labs, Bristol-Myers Squibb
Celgene's Momentum Continues
Motley Fool
Wednesday, December 12, 2012 - 8:06am
tags:
Celgene, pomalidomide, Multiple Myeloma
Teva Focuses on Central Nervous System, Respiratory Drugs
Bloomberg
Wednesday, December 12, 2012 - 8:05am
tags:
CNS, Respiratory, Teva
Amarin: 3 Things To Investigate (Further) For Vascepa
Seeking Alpha
Wednesday, December 12, 2012 - 7:33am
tags:
Amarin, Vascepa
Warburg Said to Hire Goldman Sachs to Sell Bausch & Lomb
Bloomberg
Wednesday, December 12, 2012 - 7:32am
tags:
M&A, Bausch & Lomb, Warburg Pincus
St. Jude Medical Sued Over Durata Wire Quality Assurances
Bloomberg
Wednesday, December 12, 2012 - 7:30am
tags:
Durata, St. Jude Medical, lawsuits, devices

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.